MedTrace Logo

Cupping and Serkangabin Versus Conventional Migraine Treatment

NCT01476930 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 391

Last updated 2014-11-24

No results posted yet for this study

Summary

Migraine is the most common recurrent headache. Current therapy of migraine headache consists of multiple drug groups for control of attack and prophylaxis against recurrent attacks. Emerging alternative medicine worldwide led investigators to evaluate the efficacy of cupping therapy plus SERKANGABIN syrup in treatment of migraine headache. Severity, duration and frequency of attacks of migraine headache evaluated in two groups during six months from presentation.

Conditions

  • Migraine Headache

Interventions

PROCEDURE

cupping and serkangabin syrup

wet cupping serkangabin syrup

DRUG

conventional migraine drug treatment

nortriptyline ,propranolol ,ergotamine , sumatriptan tablets

Sponsors & Collaborators

  • Birjand University of Medical Sciences

    lead OTHER

Principal Investigators

  • mohammad khodashenas roudsari, M.D. · assistant proffessor of internal medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-09-30
Completion
2011-10-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01476930 on ClinicalTrials.gov